These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 23702337)

  • 41. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network.
    Percac-Lima S; López L; Ashburner JM; Green AR; Atlas SJ
    Cancer; 2014 Jul; 120(13):2025-31. PubMed ID: 24691564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal occult blood testing: a false sense of security?
    Schnell T; Aranha GV; Sontag SJ; Tode R; Reid S; Chejfec G; Karpf J; Levine G
    Surgery; 1994 Oct; 116(4):798-802; discussion 802-3. PubMed ID: 7940181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians.
    Charters TJ; Strumpf EC; Sewitch MJ
    BMC Health Serv Res; 2013 Oct; 13():449. PubMed ID: 24168208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of stratifying by family history in colorectal cancer screening programs.
    Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
    Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
    Bae N; Park S; Lim S
    Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
    Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in behavioral outcomes between first-year and second-year participants in a community-based colorectal cancer education intervention.
    Huang JY; Shi L
    Asian Pac J Cancer Prev; 2011; 12(12):3323-9. PubMed ID: 22471474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for obstruction, perforation, or emergency admission at presentation in patients with colorectal cancer: a population-based study.
    Rabeneck L; Paszat LF; Li C
    Am J Gastroenterol; 2006 May; 101(5):1098-103. PubMed ID: 16573783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
    Lipkus IM; Green LG; Marcus A
    J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
    Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of the Czech National Colorectal Cancer screening programme -  faecal occult blood tests].
    Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).
    Rim JH; Youk T; Kang JG; Park BK; Gee HY; Kim JH; Yoo J
    Sci Rep; 2017 Jun; 7(1):2804. PubMed ID: 28584248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.